|
CN109553582A
|
|
Pyrrole glug thunder Natrium metabolism object and preparation method thereof
|
|
CN111035763A
|
|
A pharmaceutical composition for treating female climacteric syndrome
|
|
CN109096251A
|
|
Compound and purposes with the dual antagonistic activity of histamine receptor
|
|
CN108929273A
|
|
A kind of preparation method of imidazole ethyl vanillic acid ether sodium salt
|
|
CN108992454A
|
|
A kind of compound medicament composition for treating dermal inflammatory disease
|
|
CN108383788A
|
|
A kind of preparation method of dimemorfan isomers
|
|
CN108299301A
|
|
A method of preparing high-purity dimemorfan
|
|
CN108484502A
|
|
A method of preparing Dimemorfan phosphate
|
|
CN108148085A
|
|
With compound, preparation method and its medicinal usage for inhibiting phosphodiesterase 4
|
|
CN107602534A
|
|
Compound with antihistamine and anti-inflammatory activity and its preparation method and application
|
|
CN107043361A
|
|
Treat anginal compound, Preparation method and use
|
|
CN106831840A
|
|
One class has micromolecular compound, preparation method and its medicinal usage of anti-inflammatory activity
|
|
CN108623629A
|
|
One kind treatment thrombus diseases related compound, preparation method and its medicinal usage
|
|
CN104000825A
|
|
Compound medicine composition containing bilastine and dimemorfan phosphate
|
|
CN104042615A
|
|
Pharmaceutical composition containing desloratadine and dimemorfan phosphate
|
|
CN104000822A
|
|
Compound cold medicinal composition containing bilastine
|
|
CN104000826A
|
|
Compound pharmaceutical composition containing desloratadine citrate disodium and dimemorfan phosphate
|
|
CN103408501A
|
|
Benzyl pyrimidine derivatives, and preparation method and medical application thereof
|
|
CN103319473A
|
|
Two crystal forms of azilsartan and preparation method thereof
|
|
CN101851209A
|
|
Imidazole ethyl vanillic acid ether, preparation method and medicinal application thereof
|
